Filings & corporate actions
- 3 NovresultsResults · Q2 FY27 · consolidated and standalone-0.3%NSE
- 16 OctshareholdingShareholding · 30 Sept 2026-1.9%NSE
- 12 AugresultsResults · Q1 FY27 · consolidated and standalone-0.7%NSE
- 11 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
- 27 MayresultsResults · Q4 FY26 · consolidated and standalone-2.0%NSE
- 13 AprshareholdingShareholding · 31 Mar 2026-0.1%NSE
- 11 FebresultsResults · Q3 FY26 · consolidated and standalone-6.2%NSE
- 21 JanshareholdingShareholding · 31 Dec 2025-1.0%NSE
Reaction to results · all yearsrose on day 0 in 13 of 38 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 3 Nov 2026 | -0.3% | +2.0% | — | 2.1× |
| Q1 FY27 | 12 Aug 2026 | -0.7% | -1.7% | -7.2% | 1.3× |
| Q4 FY26 | 27 May 2026 | -2.0% | +0.9% | -0.4% | 2.5× |
| Q3 FY26 | 11 Feb 2026 | -6.2% | -12.8% | -19.8% | 2.5× |
| Q2 FY26 | 13 Nov 2025 | -2.4% | -5.7% | -16.0% | 1.8× |
| Q1 FY26 | 13 Aug 2025 | -2.5% | -4.8% | +11.7% | 0.8× |
| Q4 FY25 | 29 May 2025 | -4.8% | -8.1% | -7.4% | 3.4× |
| Q3 FY25 | 3 Feb 2025 | -3.7% | -6.4% | -10.2% | 3.1× |
| Q2 FY25 | 30 Oct 2024 | -2.9% | -4.4% | -4.5% | 2.6× |
| Q1 FY25 | 8 Jul 2024 | -0.9% | +0.9% | -10.2% | 1.0× |
| Q4 FY24 | 29 May 2024 | +1.2% | -2.2% | +0.7% | 1.7× |
| Q3 FY24 | 7 Feb 2024 | -2.4% | -4.3% | -20.4% | 0.7× |
| Q2 FY24 | 27 Oct 2023 | +1.1% | +11.6% | +23.2% | 0.8× |
| Q1 FY24 | 20 Jul 2023 | -0.1% | +3.7% | +4.3% | 1.2× |
| Q4 FY23 | 19 May 2023 | +0.4% | -0.9% | +11.0% | 1.3× |
| Q3 FY23 | 18 Jan 2023 | -2.3% | -6.4% | -13.9% | 2.0× |
| Q2 FY23 | 19 Oct 2022 | +0.8% | -1.7% | -1.2% | 1.7× |
| Q4 FY22 | 26 May 2022 | +1.8% | +11.0% | -4.6% | 0.7× |
| Q3 FY22 | 2 Feb 2022 | +1.5% | +2.4% | -11.3% | 1.0× |
| Q2 FY22 | 26 Oct 2021 | -2.7% | -5.1% | -9.4% | 0.8× |
| Q1 FY22 | 10 Aug 2021 | -8.4% | -9.0% | -8.4% | 3.1× |
| Q4 FY21 | 6 May 2021 | -2.6% | +15.8% | +24.9% | 2.0× |
| Q3 FY21 | 8 Jan 2021 | -5.4% | -8.0% | -10.5% | 0.8× |
| Q2 FY21 | 12 Oct 2020 | +2.4% | -7.6% | -8.3% | 9.2× |
| Q1 FY21 | 5 Sept 2020 | +1.1% | -1.5% | +3.8% | 0.4× |
| Q4 FY20 | 16 Jun 2020 | -1.9% | +5.9% | +7.1% | 0.3× |
| Q3 FY20 | 4 Feb 2020 | +2.1% | +2.0% | -18.5% | 0.3× |
| Q2 FY20 | 11 Nov 2019 | -8.5% | -7.8% | -17.6% | 1.2× |
| Q1 FY20 | 30 Jul 2019 | +6.0% | +0.3% | -3.3% | 28.4× |
| Q4 FY19 | 21 Jun 2019 | +0.9% | -1.7% | -20.4% | 0.4× |
| Q3 FY19 | 30 Jan 2019 | -0.6% | -0.5% | -0.2% | 0.8× |
| Q2 FY19 | 30 Oct 2018 | -0.3% | +7.7% | +3.0% | 0.6× |
| Q4 FY17 | 10 Sept 2018 | -1.1% | -8.0% | -18.3% | 1.2× |
| Q4 FY18 | 10 Sept 2018 | -1.1% | -8.0% | -18.3% | 1.2× |
| Q1 FY18 | 30 Aug 2018 | +0.6% | +11.1% | -10.2% | 2.0× |
| Q1 FY19 | 30 Aug 2018 | +0.6% | +11.1% | -10.2% | 2.0× |
| Q2 FY18 | 10 Jan 2018 | -5.6% | -10.0% | -11.0% | — |
| Q3 FY18 | 10 Jan 2018 | -5.6% | -10.0% | -11.0% | — |
| Average | -1.4% | -1.3% | -5.8% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +9.4% | +11.2% | — | — | +21.0% | — |
| Profit | -14.2% | -20.4% | — | — | +33.9% | — |
Key data
Delivery percentage
Over the last 20 sessions SHALBY settled 62.2% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 53.1%, so recent sessions are running 9.0 points higher than usual. The latest session ranks higher than 60% of the 2,200 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.21% | -1.54% | +6.04% | -20.97% | -28.35% | -45.67% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 272.1 | 287.4 | 331.2 | 313.2 |
| YoY chg | -1.3% | +8.5% | +11.7% | +9.7% |
| Net profit (₹ Cr) | 1.3 | 18.5 | 10.5 | 7.9 |
| YoY chg | — | — | +36.7% | +8.3% |
| Net margin | 0.5% | 6.4% | 3.2% | 2.5% |
| EPS | 0.12 | 1.72 | 0.98 | 0.73 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 74.33% · public 25.05%- Promoter
- Public and others
- Promoter
- 74.33%
- Public
- 25.05%
- Promoter change
- 0.00 pp
- Filed
- 16 Oct 2026
- FII
- 4.65%
- DII
- 0.31%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 0.02%
- Insurance
- 0.00%
- FPI
- 4.65%
- Retail ≤ ₹2L
- 9.66%
- HNI > ₹2L
- 2.39%
- NRI
- 1.06%
- Bodies corporate
- 6.18%
- Shareholders
- 50,572
+0.01 pp QoQ
0.00 pp QoQ
+0.18 pp QoQ
+0.31 pp QoQ
-0.38 pp QoQ
+0.07 pp QoQ
-0.16 pp QoQ
-0.4% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| SHAH FAMILY TRUST THROUH DR. VIKRAM SHAH, TRUSTEE | Promoter · Other | 34.79% | 3.76Cr |
| ZODIAC MEDIQUIP LIMITED | Promoter · Corporate | 29.21% | 3.15Cr |
| VIKRAM INDRAJIT SHAH | Promoter · Individual | 7.42% | 80.10L |
| DARSHINI VIKRAM SHAH | Promoter · Individual | 2.79% | 30.13L |
| FIRST WATER FUND | FPI | 1.81% | 19.51L |
| SHANAY VIKRAM SHAH | Promoter · Individual | 0.13% | 1.38L |
| SHAH KAIRAV KIRITKUMAR | Promoter · Individual | 0.00% | 250 |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2024-25 | 1 | ₹1.20 | ₹1.20 |
| FY2023-24 | 1 | ₹1.20 | ₹1.20 |
| FY2022-23 | 1 | ₹1.00 | ₹1.00 |
| FY2021-22 | 1 | ₹1.00 | ₹1.00 |
| FY2020-21 | 1 | ₹0.50 | ₹0.50 |
| FY2019-20 | 1 | ₹0.50 | ₹0.50 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 19 Sept 2024 | — | ₹1.20 | ₹1.20 |
| 8 Aug 2023 | — | ₹1.20 | ₹1.20 |
| 19 Sept 2022 | — | ₹1.00 | ₹1.00 |
| 17 Sept 2021 | — | ₹1.00 | ₹1.00 |
| 4 Sept 2020 | — | ₹0.50 | ₹0.50 |
| 16 Aug 2019 | — | ₹0.50 | ₹0.50 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 3 months ago
- Disclosures on record
- 25
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | VIKRAM INDRAJIT SHAHPromoter | Buy | 5.0K | ₹7.7L | 154.72 | 80.05L → 80.10L | 7.42%+0.00 pp | 7(2)told 21 Aug 2026 |
| 20 Sept 2025 | SHAH FAMILY TRUST THROUGH DR. VIKRAM I SHAH, TRUSTEEPromoter | Buy | 60.0K | ~₹1.4Cr | 240.57 | 3.75Cr → 3.76Cr | 34.79%+0.06 pp | 7(2)told 20 Sept 2025 |
| 15 Nov 2024 | DR. VIKRAM INDRAJIT SHAHOther | Buy | 25.0K | ₹54.5L | 218.20 | 79.80L → 80.05L | 7.41%+0.02 pp | 7(2)told 15 Nov 2024 |
| 6 Jun 2024 | DR. VIKRAM INDRAJIT SHAHPromoter | Buy | 10.0K | ₹25.4L | 254.16 | 79.70L → 79.80L | 7.39%+0.01 pp | 7(2)told 5 Jun 2024 |
| 7 Mar 2024 | VIKRAM INDRAJIT SHAHPromoter | Buy | 1.25L | ₹3.1Cr | 244.20 | 78.45L → 79.70L | 7.38%+0.12 pp | 7(2)told 7 Mar 2024 |
| 8 Dec 2022 | VIKRAM INDRAJIT SHAHPromoter | Buy | 30.0K | ₹44.9L | 149.63 | 78.15L → 78.45L | 7.27%+0.03 pp | 7(2)told 8 Dec 2022 |
| 29 Nov 2022 | VIKRAM INDRAJIT SHAHPromoter | Buy | 20.0K | ₹30.3L | 151.67 | 77.95L → 78.15L | 7.24%+0.02 pp | 7(2)told 29 Nov 2022 |
| 17 Nov 2022 | VIKRAM INDRAJIT SHAHPromoter | Buy | 20.0K | ₹28.7L | 143.51 | 77.75L → 77.95L | 7.22%+0.02 pp | 7(2)told 16 Nov 2022 |
| 4 Nov 2022 | VIKRAM INDRAJIT SHAHPromoter | Buy | 20.0K | ₹29.0L | 144.88 | 77.55L → 77.75L | 7.20%+0.02 pp | 7(2)told 4 Nov 2022 |
| 27 Oct 2022 | Neelu Pratik KediaRelative | Sell | 530 | ₹76,919 | 145.13 | 530 → — | 0.00% | 7(2)told 26 Oct 2022 |
| 1 Jun 2022 | VIKRAM INDRAJIT SHAHPromoter | Buy | 10.0K | ₹11.1L | 111.27 | 77.35L → 77.45L | 7.17%+0.01 pp | 7(2)told 1 Jun 2022 |
| 31 May 2022 | Shalby Limited Employees Welfare TrustOther | Buy | 7.00L | ₹7.5Cr | 107.75 | — → 7.00L | 0.65% | 7(2)told 31 May 2022 |
| 13 Aug 2021 | KAIRAV KIRIT SHAHPromoter | Sell | 57.3K | ₹1.1Cr | 188.75 | 57.3K → — | 0.00% | 7(2)told 12 Aug 2021 |
| 26 Sept 2020 | KAIRAV KIRIT SHAHPromoter | Buy | 500 | ₹40,659 | 81.32 | 56.8K → 57.3K | 0.05%+0.00 pp | 7(2)told 24 Sept 2020 |
| 21 Sept 2020 | KAIRAV KIRIT SHAHPromoter | Buy | 3.5K | ₹2.9L | 83.62 | 53.3K → 56.8K | 0.05%+0.00 pp | 7(2)told 19 Sept 2020 |
| 18 Sept 2020 | KAIRAV KIRIT SHAHPromoter | Buy | 6.0K | ₹4.8L | 79.47 | 47.3K → 53.3K | 0.05%+0.01 pp | 7(2)told 18 Sept 2020 |
| 26 Feb 2020 | KAIRAV KIRIT SHAHPromoter | Buy | 8.2K | ₹7.7L | 93.40 | 39.1K → 47.3K | 0.04%+0.01 pp | 7(2)told 25 Feb 2020 |
| 1 Jun 2019 | KAIRAV KIRIT SHAHPromoter | Buy | 12.2K | ₹15.5L | 127.03 | 26.9K → 39.1K | 0.04%+0.01 pp | 7(2)told 31 May 2019 |
| 30 May 2019 | KAIRAV KIRIT SHAHPromoter | Buy | 4.5K | ₹5.8L | 127.84 | 22.4K → 26.9K | 0.02%+0.00 pp | 7(2)told 29 May 2019 |
| 30 May 2019 | KAIRAV KIRIT SHAHPromoter | Buy | 7.4K | ₹9.6L | 129.53 | 15.0K → 22.4K | 0.02%+0.01 pp | 7(2)told 29 May 2019 |
| 24 Feb 2018 | KAIRAV KIRIT SHAHPromoter | Buy | 5.0K | ₹11.8L | 235.26 | 10.0K → 15.0K | 0.01%+0.00 pp | 7(2)told 23 Feb 2018 |
| 2 Jan 2018 | KAIRAV KIRIT SHAHPromoter | Buy | 1.0K | ₹2.2L | 222.99 | 9.0K → 10.0K | 0.01%+0.00 pp | 7(2)told 1 Jan 2018 |
| 2 Jan 2018 | KAIRAV KIRIT SHAHPromoter | Buy | 7.0K | ₹16.8L | 239.70 | 2.0K → 9.0K | 0.01%+0.01 pp | 7(2)told 1 Jan 2018 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 22 Sept 2025
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 22 Sept 2025 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 13.54L | 266.55 | ₹36.1Cr |
| 22 Sept 2025 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 13.54L | 266.34 | ₹36.1Cr |
| 5 Sept 2025 | Sell · bulk | NK SECURITIES RESEARCH PRIVATE LIMITED | 5.69L | 223.57 | ₹12.7Cr |
| 5 Sept 2025 | Buy · bulk | NK SECURITIES RESEARCH PRIVATE LIMITED | 5.69L | 223.40 | ₹12.7Cr |
| 5 Sept 2025 | Sell · bulk | MUSIGMA SECURITIES | 5.48L | 223.36 | ₹12.2Cr |
| 5 Sept 2025 | Buy · bulk | MUSIGMA SECURITIES | 5.48L | 223.24 | ₹12.2Cr |
| 13 Jun 2025 | Buy · block, also bulk | FIRST WATER FUND | 7.00L | 180.00 | ₹12.6Cr |
| 13 Jun 2025 | Sell · block, also bulk | HARESH TIKAMDAS KASWANI | 7.00L | 180.00 | ₹12.6Cr |
| 28 Mar 2023 | Buy · bulk | EQUITY INTELLIGENCE INDIA PRIVATE LIMITED | 6.10L | 117.00 | ₹7.1Cr |
| 30 May 2022 | Buy · bulk | SHALBY LIMITED EMPLOYEES WELFARE TRUST | 7.00L | 107.50 | ₹7.5Cr |
| 30 May 2022 | Sell · bulk | SHALBY MEDICOS TRUST | 7.00L | 107.50 | ₹7.5Cr |
| 5 Jul 2021 | Buy · bulk | OLGA TRADING PRIVATE LIMITED | 5.43L | 192.02 | ₹10.4Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.
Exchange surveillance
No surveillance measure applies to SHALBY.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 216.0 | 244.2 | 278.9 | 267.5 | 275.6 | 264.9 | 296.4 | 285.4 | 272.1 | 287.4 | 331.2 | 313.2 | |
| Other income | 4.5 | 5.0 | 9.7 | 7.2 | 5.4 | 5.3 | 7.0 | 4.5 | 7.2 | 8.1 | 7.4 | 5.0 | |
| Total income | 220.6 | 249.2 | 288.6 | 274.7 | 281.1 | 270.2 | 303.4 | 289.9 | 279.4 | 295.5 | 338.6 | 318.2 | |
| Total expenses | 189.8 | 227.4 | 258.2 | 261.0 | 268.7 | 271.0 | 280.8 | 270.8 | 270.1 | 285.9 | 318.9 | 301.7 | |
| └ Finance costs | 3.6 | 6.5 | 8.1 | 9.3 | 10.7 | 10.7 | 9.4 | 9.6 | 10.6 | 9.3 | 10.6 | 11.0 | |
| └ Depreciation | 12.4 | 15.6 | 16.4 | 16.8 | 16.3 | 16.2 | 16.5 | 17.4 | 17.6 | 18.5 | 18.7 | 18.9 | |
| Profit before tax | 30.8 | 21.8 | 30.4 | 13.7 | 12.4 | (0.7) | 22.7 | 19.1 | 9.2 | 9.6 | 19.7 | 16.5 | |
| Tax expense | 11.7 | 5.7 | 15.7 | 11.3 | 15.3 | 11.4 | 15.0 | 11.8 | 8.0 | (8.8) | 9.2 | 8.6 | |
| Net profit | 19.1 | 16.0 | 14.7 | 2.4 | (3.0) | (12.2) | 7.7 | 7.3 | 1.3 | 18.5 | 10.5 | 7.9 | |
| EPS | 1.78 | 1.49 | 1.37 | 0.22 | -0.28 | -1.13 | 0.71 | 0.68 | 0.12 | 1.72 | 0.98 | 0.73 | |
| Net margin | 8.82% | 6.57% | 5.29% | 0.88% | -1.09% | -4.60% | 2.59% | 2.55% | 0.47% | 6.42% | 3.17% | 2.52% | |
| PBT margin | 14.26% | 8.92% | 10.90% | 5.12% | 4.48% | -0.28% | 7.64% | 6.68% | 3.39% | 3.34% | 5.95% | 5.26% | |
| Tax rate | 38.13% | 26.35% | 51.53% | 82.78% | 124.23% | — | 66.11% | 61.84% | 86.15% | -92.11% | 46.71% | 52.13% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 3 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,281.4 | 1,315.7 | 1,607.5 | 1,716.6 | 1,703.7 | 1,782.4 | 1,839.1 | 1,857.0 | |
| Current assets | 544.0 | 581.7 | 552.3 | 677.9 | 658.0 | 694.3 | 719.3 | 749.8 | |
| └ Cash & equivalents | 12.2 | 10.0 | 27.2 | 36.8 | 34.8 | 19.0 | 21.9 | 21.4 | |
| └ Other bank balances | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| └ Current investments | 145.7 | 133.9 | 80.6 | 111.8 | 94.6 | 87.2 | 62.3 | 48.1 | |
| └ Trade receivables | 106.4 | 138.7 | 144.6 | 171.4 | 175.2 | 185.8 | 228.4 | 276.6 | |
| └ Inventories | 185.4 | 205.8 | 235.2 | 276.0 | 319.2 | 346.6 | 376.4 | 374.7 | |
| Total equity | 927.6 | 963.8 | 1,007.8 | 1,012.1 | 995.3 | 1,002.8 | 1,005.7 | 1,022.0 | |
| └ Attributable to owners | 927.7 | 963.8 | 1,000.4 | 1,006.6 | 992.2 | 1,002.0 | 1,005.2 | 1,022.0 | |
| └ Non-controlling interest | (0.1) | (0.1) | 7.4 | 5.5 | 3.1 | 0.8 | 0.5 | — | |
| └ Share capital | 107.3 | 107.3 | 107.4 | 107.5 | 107.5 | 107.5 | 107.5 | 107.6 | |
| Borrowings | 180.5 | 160.9 | 314.0 | 405.7 | 426.7 | 486.7 | 539.6 | 537.1 | |
| └ Current | 78.9 | 71.9 | 138.0 | 259.1 | 290.0 | 339.9 | 386.7 | 392.4 | |
| └ Non-current | 101.6 | 89.0 | 176.0 | 146.6 | 136.7 | 146.8 | 152.9 | 144.7 | |
| Trade payables | 87.9 | 94.3 | 129.6 | 119.2 | 118.4 | 131.0 | 128.5 | 153.6 | |
| Current liabilities | 194.4 | 193.2 | 323.3 | 450.0 | 455.3 | 521.2 | 575.7 | 595.6 | |
| Total liabilities | 353.7 | 351.9 | 599.7 | 704.5 | 708.3 | 779.6 | 833.4 | 835.0 | |
| Net debt | 22.5 | 16.9 | 206.1 | 257.1 | 297.2 | 380.5 | 455.4 | 467.5 | |
| Debt / equity | 0.19 | 0.17 | 0.31 | 0.40 | 0.43 | 0.49 | 0.54 | 0.53 | |
| Current ratio | 2.80 | 3.01 | 1.71 | 1.51 | 1.45 | 1.33 | 1.25 | 1.26 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 67.8 | 30.7 | 19.6 | 11.5 | (4.3) | 13.8 | (0.0) | 40.1 | |
| └ Capex | (18.5) | (15.9) | (47.1) | (32.9) | (71.4) | (81.0) | (149.0) | (30.8) | |
| Free cash flow | 49.3 | 14.8 | (27.5) | (21.5) | (75.8) | (67.1) | (149.1) | 9.3 | |
| Investing cash flow | (61.1) | 5.7 | 38.1 | (57.1) | (35.6) | (69.3) | (97.3) | (10.2) | |
| Financing cash flow | (50.0) | (38.5) | (150.7) | 55.2 | 47.6 | 39.6 | 84.4 | (30.3) | |
| └ Dividends paid | (10.8) | (13.0) | (13.0) | (13.0) | (13.0) | 0.0 | 0.0 | 0.0 | |
| └ Buybacks | (7.5) | 0.0 | (205.9) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | (43.3) | (2.2) | (93.0) | 9.6 | 7.6 | (15.8) | (12.9) | (0.5) |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →SHALBY at a glance
- SHALBY closed at ₹122.15 on 20 Nov 2026, +0.21% on the day, -45.7% over one year, 46.3% below its 52-week high of ₹227.66.
- Delivery was 54.3% of traded quantity on 20 Nov 2026, the 60th percentile of its own 2,200 sessions with a reading (20-session average 62.2%, 1-year average 53.1%).
- Market capitalisation is ₹1,319 crore at a trailing P/E of 33.7 (trailing EPS ₹3.63).
- Q2 FY27 results (consolidated, filed 3 Nov 2026): revenue ₹313 crore (+9.7% year on year), net profit ₹8 crore (+8.3%); the price moved -0.3% on the first session after.
- Promoters held 74.33% at 30 Sept 2026, unchanged on the previous filing.
- Q3 FY27 results are expected between 18 Jan 2027 and 11 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Healthcare Services
- APAPOLLOHOSPApollo Hospitals Enterprise Limited9,200.00+5.29%
- MAMAXHEALTHMax Healthcare Institute Limited1,081.00+3.88%
- PAPARASHLTHPARASHLTH844.65+1.16%
- FOFORTISFortis Healthcare Limited825.00+1.87%
- SYSYNGENESyngene International Limited451.70+3.28%
- ASASTERDMAster DM Quality Care Limited779.30+5.41%
- MAMANIPALHOSManipal Health Enterprises Limited702.20+0.83%
- LALALPATHLABDr. Lal Path Labs Ltd.2,006.00+2.18%
- THTHYROCAREThyrocare Technologies Limited528.45+4.67%
- ININDGNIndegene Limited657.65+1.90%
- MEMEDANTAGlobal Health Limited1,480.20+0.13%
- NHNHNarayana Hrudayalaya Ltd.1,943.70+3.77%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE